用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 ' NOVARTIS AG [CH]'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页上页123尾页25 条记录, 当前第3/3页。
公开号 公开日 申请号 申请日
1. US2012148619A1 2012/6/14 US201213403865 2012/2/23
专利标题:ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN 法律状态
Factor H binding protein (fHBP) has been proposed for use in immunising against serogroup B meningococcus ('MenB'). This antigen can be efficiently adsorbed to an aluminium hydroxyphosphate adjuvant by (i) ensuring that adsorption takes place at a pH which is equal to or below the adjuvant's point of zero charge (PZC), and/or (ii) selecting a fHBP and adjuvant with an isoelectric point/PZC within the range of 5.0 to 7, and/or (iii) selecting a fHBP with an isoelectric point above the adjuvant's ...


2. US2012122764A1 2012/5/17 US201113293560 2011/11/10
专利标题:SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP 法律状态
The present invention provides a compound of formula I


3. US2012070458A1 2012/3/22 US201013260534 2010/3/24
专利标题:ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN 法律状态
Factor H binding protein (fHBP) has been proposed for use in immunising against serogroup B meningococcus ('MenB'). This antigen can be efficiently adsorbed to an aluminium hydroxyphosphate adjuvant by (i) ensuring that adsorption takes place at a pH which is equal to or below the adjuvant's point of zero charge (PZC), and/or (ii) selecting a fHBP and adjuvant with an isoelectric point/PZC within the range of 5.0 to 7, and/or (iii) selecting a fHBP with an isoelectric point above the adjuvant's ...


4. US2012029084A1 2012/2/2 US201113253648 2011/10/5
专利标题:Topical Nepafenac Formulations 法律状态
Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.


5. IL199916A 2011/6/30 IL20090199916 2009/7/16
专利标题:ZINC FINGER NUCLEOTIDE BINDING POLYPEPTIDE THAT INCLUDES A NUCLEOTIDE BINDING REGION 法律状态



首页上页123尾页25 条记录, 当前第3/3页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文